Stock Information
BioMarin Pharmaceutical Inc (BMRN)
Ticker Symbol: BMRN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $10,253,579,693.00 mil
Piotroski score: 6
PE Ratio: 23.0759
EPS (TTM): 2.6403
Revenue (TTM): $16.11 M
Dividend Yield: N/A%
ROE: 8.84%
Latest News
-
Update: BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 Billion; Shares Jump
Fri, Dec 19, 2025 3:03 PM
-
Stocks to Watch Friday: Lamb Weston, Nike, Oracle, FedEx
Fri, Dec 19, 2025 2:38 PM
-
BioMarin Pharmaceutical Scoops Up Amicus Therapeutics In $4.8 Billion Deal
Fri, Dec 19, 2025 2:33 PM
-
BioMarin to Buy Amicus Therapeutics for $4.8 Billion
Fri, Dec 19, 2025 2:08 PM
-
BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 billion
Fri, Dec 19, 2025 1:33 PM
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
Fri, Dec 19, 2025 12:45 PM
-
BioMarin Pharmaceutical Inc. (BMRN) M&A Call Transcript
Fri, Dec 19, 2025 11:27 AM
-
1 Oversold Stock Primed to Rebound and 2 That Underwhelm
Tue, Dec 16, 2025 4:38 AM
-
Do Options Traders Know Something About BMRN Stock We Don't?
Mon, Dec 15, 2025 6:16 PM
Key Financials
Financial data not available
